Works matching IS 02698811 AND DT 2024 AND VI 38 AND IP 8


Results: 8
    1
    2
    3

    A framework for assessment of adverse events occurring in psychedelic-assisted therapies.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 8, p. 690, doi. 10.1177/02698811241265756
    By:
    • Palitsky, Roman;
    • Kaplan, Deanna M;
    • Perna, John;
    • Bosshardt, Zachary;
    • Maples-Keller, Jessica L;
    • Levin-Aspenson, Holly F;
    • Zarrabi, Ali John;
    • Peacock, Caroline;
    • Mletzko, Tanja;
    • Rothbaum, Barbara O;
    • Raison, Charles L;
    • Grant, George H;
    • Dunlop, Boadie W
    Publication type:
    Article
    5
    6
    7
    8

    Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healthy participants.

    Published in:
    Journal of Psychopharmacology, 2024, v. 38, n. 8, p. 712, doi. 10.1177/02698811241246857
    By:
    • Rucker, James Jonathan;
    • Roberts, Claire;
    • Seynaeve, Mathieu;
    • Young, Allan H.;
    • Suttle, Ben;
    • Yamamoto, Takahiro;
    • Ermakova, Anna O.;
    • Dunbar, Fiona;
    • Wiegand, Frank
    Publication type:
    Article